Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 12, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 14, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001773751-26-000191
Filed / recorded
Aug 14, 2026, 8:16 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Hims & Hers Health, Inc.
Issuer CIK
1773751
Ticker
HIMS
Reporting person
Christopher D Payne
Relationship
Director
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
Aug 12, 2026
Transaction code
A
Shares / units
545
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
545
Ownership form
Direct
Amendment
No
Footnotes from the filing
The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.